NextSeq2000 Sequencing System

Concepts

• biomedical equipment
• londonderry
• western health
• western health and social care trust
• social care trust
• sequencing system
• system
• illumina
• illumina nextseq
• platform

Location

Northern Ireland:

Description

The Western Health and Social Care Trust intend to enter into an agreement with Illumina for an Illumina NextSeq 2000 platform under regulation 32(2)(b).

Total Quantity or Scope

Illumina NextSeq2000 Sequencing system

Award Detail

Award Criteria

CPV Codes

• 38434540 - Biomedical equipment

Legal Justification

The Western Health and Social Care Trust are relying on regulation 32(2)(b), competition is absent for technical reasons. Illumina is the sole supplier of this specific high throughput sequencing technology/ platform. Illumina sequencing technology, sequencing by synthesis (SBS), is a widely adopted next-generation sequencing (NGS) technology worldwide. Illumina sequencing instruments and reagents support massively parallel, high-throughput sequencing using a proprietary method that detects single bases as they are incorporated into growing DNA strands. Nextseq2000 provides higher sensitivity to detect low-frequency variants, faster turnaround time for high sample volumes, comprehensive genomic coverage, lower limit of detection, higher capacity with sample multiplexing, ability to sequence hundreds to thousands of genes or gene regions simultaneously.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** On September 29, 2022, a VEAT was published (Notice reference 2022/S 000-027286), and no challenges were received within the ten-day standstill period. The initial VEAT was only for the purchase of the equipment, but the Contract Award Notice includes subsequent maintenance, which will be paid for by CTRIC rather than the Western Health and Social Care Trust, thus the disparity in values.